United States Angioplasty Peripheral Drug Eluting Balloon Market Report 2016

September 2016 | 124 pages | ID: UAAE2242F10EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Angioplasty Peripheral Drug Eluting Balloon

Revenue, means the sales value of Angioplasty Peripheral Drug Eluting Balloon

This report studies sales (consumption) of Angioplasty Peripheral Drug Eluting Balloon in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bayer HealthCare AG
• AngioCure, In
• AVIDAL Vascular GmbH
• AnGes MG, Inc
• Contego Medical
• Elixir Medical
• eucatech AG
• Lifetech Scientific (Shenzhen) Co., Ltd
• Medtronic plc
• Micell Technologies, Inc
• Nipro Corporation
• NuVascular Technologies Inc
• QT Vascular Ltd
• QualiMed Innovative Medizinprodukte GmbH
• Rontis AG

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Angioplasty Peripheral Drug Eluting Balloon in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Angioplasty Peripheral Drug Eluting Balloon Market Report 2016

1 ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOON OVERVIEW

1.1 Product Overview and Scope of Angioplasty Peripheral Drug Eluting Balloon
1.2 Classification of Angioplasty Peripheral Drug Eluting Balloon
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Angioplasty Peripheral Drug Eluting Balloon
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Angioplasty Peripheral Drug Eluting Balloon (2011-2021)
  1.4.1 USA Angioplasty Peripheral Drug Eluting Balloon Sales and Growth Rate (2011-2021)
  1.4.2 USA Angioplasty Peripheral Drug Eluting Balloon Revenue and Growth Rate (2011-2021)

2 USA ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOON COMPETITION BY MANUFACTURERS

2.1 USA Angioplasty Peripheral Drug Eluting Balloon Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Angioplasty Peripheral Drug Eluting Balloon Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Angioplasty Peripheral Drug Eluting Balloon Average Price by Manufactures (2015 and 2016)
2.4 Angioplasty Peripheral Drug Eluting Balloon Market Competitive Situation and Trends
  2.4.1 Angioplasty Peripheral Drug Eluting Balloon Market Concentration Rate
  2.4.2 Angioplasty Peripheral Drug Eluting Balloon Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOON SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Angioplasty Peripheral Drug Eluting Balloon Sales and Market Share by Type (2011-2016)
3.2 USA Angioplasty Peripheral Drug Eluting Balloon Revenue and Market Share by Type (2011-2016)
3.3 USA Angioplasty Peripheral Drug Eluting Balloon Price by Type (2011-2016)
3.4 USA Angioplasty Peripheral Drug Eluting Balloon Sales Growth Rate by Type (2011-2016)

4 USA ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOON SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Angioplasty Peripheral Drug Eluting Balloon Sales and Market Share by Application (2011-2016)
4.2 USA Angioplasty Peripheral Drug Eluting Balloon Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOON MANUFACTURERS PROFILES/ANALYSIS

5.1 Bayer HealthCare AG
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bayer HealthCare AG Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AngioCure, In
  5.2.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AngioCure, In Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 AVIDAL Vascular GmbH
  5.3.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 AVIDAL Vascular GmbH Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 AnGes MG, Inc
  5.4.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 AnGes MG, Inc Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Contego Medical
  5.5.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Contego Medical Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Elixir Medical
  5.6.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Elixir Medical Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 eucatech AG
  5.7.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 eucatech AG Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Lifetech Scientific (Shenzhen) Co., Ltd
  5.8.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Lifetech Scientific (Shenzhen) Co., Ltd Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Medtronic plc
  5.9.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Medtronic plc Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Micell Technologies, Inc
  5.10.2 Angioplasty Peripheral Drug Eluting Balloon Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Micell Technologies, Inc Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Nipro Corporation
5.12 NuVascular Technologies Inc
5.13 QT Vascular Ltd
5.14 QualiMed Innovative Medizinprodukte GmbH
5.15 Rontis AG

6 ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOON MANUFACTURING COST ANALYSIS

6.1 Angioplasty Peripheral Drug Eluting Balloon Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Angioplasty Peripheral Drug Eluting Balloon

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Angioplasty Peripheral Drug Eluting Balloon Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Angioplasty Peripheral Drug Eluting Balloon Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOON MARKET FORECAST (2016-2021)

10.1 USA Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue Forecast (2016-2021)
10.2 USA Angioplasty Peripheral Drug Eluting Balloon Sales Forecast by Type (2016-2021)
10.3 USA Angioplasty Peripheral Drug Eluting Balloon Sales Forecast by Application (2016-2021)
10.4 Angioplasty Peripheral Drug Eluting Balloon Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Angioplasty Peripheral Drug Eluting Balloon
Table Classification of Angioplasty Peripheral Drug Eluting Balloon
Figure USA Sales Market Share of Angioplasty Peripheral Drug Eluting Balloon by Type in 2015
Table Application of Angioplasty Peripheral Drug Eluting Balloon
Figure USA Sales Market Share of Angioplasty Peripheral Drug Eluting Balloon by Application in 2015
Figure USA Angioplasty Peripheral Drug Eluting Balloon Sales and Growth Rate (2011-2021)
Figure USA Angioplasty Peripheral Drug Eluting Balloon Revenue and Growth Rate (2011-2021)
Table USA Angioplasty Peripheral Drug Eluting Balloon Sales of Key Manufacturers (2015 and 2016)
Table USA Angioplasty Peripheral Drug Eluting Balloon Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Angioplasty Peripheral Drug Eluting Balloon Sales Share by Manufacturers
Figure 2016 Angioplasty Peripheral Drug Eluting Balloon Sales Share by Manufacturers
Table USA Angioplasty Peripheral Drug Eluting Balloon Revenue by Manufacturers (2015 and 2016)
Table USA Angioplasty Peripheral Drug Eluting Balloon Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Angioplasty Peripheral Drug Eluting Balloon Revenue Share by Manufacturers
Table 2016 USA Angioplasty Peripheral Drug Eluting Balloon Revenue Share by Manufacturers
Table USA Market Angioplasty Peripheral Drug Eluting Balloon Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Angioplasty Peripheral Drug Eluting Balloon Average Price of Key Manufacturers in 2015
Figure Angioplasty Peripheral Drug Eluting Balloon Market Share of Top 3 Manufacturers
Figure Angioplasty Peripheral Drug Eluting Balloon Market Share of Top 5 Manufacturers
Table USA Angioplasty Peripheral Drug Eluting Balloon Sales by Type (2011-2016)
Table USA Angioplasty Peripheral Drug Eluting Balloon Sales Share by Type (2011-2016)
Figure USA Angioplasty Peripheral Drug Eluting Balloon Sales Market Share by Type in 2015
Table USA Angioplasty Peripheral Drug Eluting Balloon Revenue and Market Share by Type (2011-2016)
Table USA Angioplasty Peripheral Drug Eluting Balloon Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Angioplasty Peripheral Drug Eluting Balloon by Type (2011-2016)
Table USA Angioplasty Peripheral Drug Eluting Balloon Price by Type (2011-2016)
Figure USA Angioplasty Peripheral Drug Eluting Balloon Sales Growth Rate by Type (2011-2016)
Table USA Angioplasty Peripheral Drug Eluting Balloon Sales by Application (2011-2016)
Table USA Angioplasty Peripheral Drug Eluting Balloon Sales Market Share by Application (2011-2016)
Figure USA Angioplasty Peripheral Drug Eluting Balloon Sales Market Share by Application in 2015
Table USA Angioplasty Peripheral Drug Eluting Balloon Sales Growth Rate by Application (2011-2016)
Figure USA Angioplasty Peripheral Drug Eluting Balloon Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare AG Basic Information List
Table Bayer HealthCare AG Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table AngioCure, In Basic Information List
Table AngioCure, In Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table AngioCure, In Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table AVIDAL Vascular GmbH Basic Information List
Table AVIDAL Vascular GmbH Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table AVIDAL Vascular GmbH Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table AnGes MG, Inc Basic Information List
Table AnGes MG, Inc Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table AnGes MG, Inc Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table Contego Medical Basic Information List
Table Contego Medical Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Contego Medical Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table Elixir Medical Basic Information List
Table Elixir Medical Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Elixir Medical Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table eucatech AG Basic Information List
Table eucatech AG Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table eucatech AG Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table Lifetech Scientific (Shenzhen) Co., Ltd Basic Information List
Table Lifetech Scientific (Shenzhen) Co., Ltd Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lifetech Scientific (Shenzhen) Co., Ltd Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table Medtronic plc Basic Information List
Table Medtronic plc Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic plc Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table Micell Technologies, Inc Basic Information List
Table Micell Technologies, Inc Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Micell Technologies, Inc Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table Nipro Corporation Basic Information List
Table Nipro Corporation Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nipro Corporation Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table NuVascular Technologies Inc Basic Information List
Table NuVascular Technologies Inc Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table NuVascular Technologies Inc Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table QT Vascular Ltd Basic Information List
Table QT Vascular Ltd Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table QT Vascular Ltd Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table QualiMed Innovative Medizinprodukte GmbH Basic Information List
Table QualiMed Innovative Medizinprodukte GmbH Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table QualiMed Innovative Medizinprodukte GmbH Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table Rontis AG Basic Information List
Table Rontis AG Angioplasty Peripheral Drug Eluting Balloon Sales, Revenue, Price and Gross Margin (2011-2016)
Table Rontis AG Angioplasty Peripheral Drug Eluting Balloon Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Angioplasty Peripheral Drug Eluting Balloon
Figure Manufacturing Process Analysis of Angioplasty Peripheral Drug Eluting Balloon
Figure Angioplasty Peripheral Drug Eluting Balloon Industrial Chain Analysis
Table Raw Materials Sources of Angioplasty Peripheral Drug Eluting Balloon Major Manufacturers in 2015
Table Major Buyers of Angioplasty Peripheral Drug Eluting Balloon
Table Distributors/Traders List
Figure USA Angioplasty Peripheral Drug Eluting Balloon Production and Growth Rate Forecast (2016-2021)
Figure USA Angioplasty Peripheral Drug Eluting Balloon Revenue and Growth Rate Forecast (2016-2021)
Table USA Angioplasty Peripheral Drug Eluting Balloon Production Forecast by Type (2016-2021)
Table USA Angioplasty Peripheral Drug Eluting Balloon Consumption Forecast by Application (2016-2021)